133 related articles for article (PubMed ID: 14670884)
1. Pulmonary embolism possibly associated with olanzapine treatment.
Waage IM; Gedde-Dahl A
BMJ; 2003 Dec; 327(7428):1384. PubMed ID: 14670884
[No Abstract] [Full Text] [Related]
2. Olanzapine-induced mania.
Reeves RR; McBride WA; Brannon GE
J Am Osteopath Assoc; 1998 Oct; 98(10):549-50. PubMed ID: 9821737
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine-induced hyperventilation: case report.
Sattar SP; Gastfriend DR
J Psychiatry Neurosci; 2002 Sep; 27(5):360-3. PubMed ID: 12271791
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine and venous thromboembolism.
Hägg S; Tätting P; Spigset O
Int Clin Psychopharmacol; 2003 Sep; 18(5):299-300. PubMed ID: 12920392
[TBL] [Abstract][Full Text] [Related]
5. Thrombocytopenia possibly associated with olanzapine and subsequently with benztropine mesylate.
Bogunovic O; Viswanathan R
Psychosomatics; 2000; 41(3):277-8. PubMed ID: 10849461
[No Abstract] [Full Text] [Related]
6. Olanzapine: a new typical antipsychotic drug.
Meltzer HY; Fibiger HC
Neuropsychopharmacology; 1996 Feb; 14(2):83-5. PubMed ID: 8822530
[No Abstract] [Full Text] [Related]
7. Paranoia and agitation associated with olanzapine treatment.
al Jeshi A
Can J Psychiatry; 1998 Mar; 43(2):195. PubMed ID: 9533976
[No Abstract] [Full Text] [Related]
8. Eosinophilia associated with olanzapine.
Mathias S; Schaaf LW; Sonntag A
J Clin Psychiatry; 2002 Mar; 63(3):246-7. PubMed ID: 11928731
[No Abstract] [Full Text] [Related]
9. Olanzapine-induced weight gain.
Gupta S; Droney T; Al-Samarrai S; Keller P; Frank B
Ann Clin Psychiatry; 1998 Mar; 10(1):39. PubMed ID: 9622049
[No Abstract] [Full Text] [Related]
10. Recurrent priapism during treatment with clozapine and olanzapine.
Compton MT; Saldivia A; Berry SA
Am J Psychiatry; 2000 Apr; 157(4):659. PubMed ID: 10777416
[No Abstract] [Full Text] [Related]
11. Weight gain and hyperglycaemia associated with olanzapine.
Riccitelli G; Baker N
Aust N Z J Psychiatry; 2002 Apr; 36(2):270-1. PubMed ID: 11982558
[No Abstract] [Full Text] [Related]
12. Hyperglycemia associated with olanzapine.
Fertig MK; Brooks VG; Shelton PS; English CW
J Clin Psychiatry; 1998 Dec; 59(12):687-9. PubMed ID: 9921705
[No Abstract] [Full Text] [Related]
13. Use of olanzapine in hereditary coproporphyria.
Strauss J; DiMartini A
Psychosomatics; 1999; 40(5):444-5. PubMed ID: 10479951
[No Abstract] [Full Text] [Related]
14. Olanzapine and tardive dyskinesia.
Woods SW
Br J Psychiatry; 1999 Oct; 175():391-2. PubMed ID: 10789313
[No Abstract] [Full Text] [Related]
15. Olanzapine-induced psychotic mania in bipolar schizoaffective disorder.
Benazzi F
Can J Psychiatry; 1999 Aug; 44(6):607-8. PubMed ID: 10497709
[No Abstract] [Full Text] [Related]
16. Esotropia associated with olanzapine.
Singh HK; Markowitz GD; Myers G
J Clin Psychopharmacol; 2000 Aug; 20(4):488. PubMed ID: 10917412
[No Abstract] [Full Text] [Related]
17. Body weight gain, insulin, and leptin in olanzapine-treated patients.
Baptista T; Beaulieu S
J Clin Psychiatry; 2001 Nov; 62(11):902-4. PubMed ID: 11775052
[No Abstract] [Full Text] [Related]
18. QTc prolongation: chlorpromazine and high-dosage olanzapine.
Gurovich I; Vempaty A; Lippmann S
Can J Psychiatry; 2003 Jun; 48(5):348. PubMed ID: 12866343
[No Abstract] [Full Text] [Related]
19. Hypomania-like syndrome induced by olanzapine.
Simon AE; Aubry JM; Malky L; Bertschy G
Int Clin Psychopharmacol; 1999 Nov; 14(6):377-8. PubMed ID: 10565806
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine, new-onset diabetes mellitus, and risk for insulin overdose.
Van Meter SA; Seaburg H; McLendon B; Doraiswamy PM
J Clin Psychiatry; 2001 Dec; 62(12):993-4. PubMed ID: 11780883
[No Abstract] [Full Text] [Related]
[Next] [New Search]
